We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, ICH Outline Updated Testing Procedures for Biologics
FDA, ICH Outline Updated Testing Procedures for Biologics
December 17, 2009
The FDA is publishing an International Conference on Harmonisation (ICH) draft guideline that updates and explains specific preclinical steps drugmakers
should take to facilitate the conduct of product development and clinical trials for biotechnology-derived drugs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor